15-min delayed · Aug 25, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Bioceres Crop Solutions Corp, 1 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $2.00 to $5.00 (about 2.5x), a sign of real disagreement on valuation. The average target of $3.50 sits 730% above the current $0.42. The rating mix has stayed broadly stable, with Buy-side ratings easing from 2 to 1 over recent months.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Moderate Buy
Strong Buy00%
Buy150%
Hold150%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Bioceres Crop Solutions Corp.
As of Aug, 1 of 2 firms rate BIOX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BIOX EPS & revenue forecast
EPS · NEXT QUARTER
—
Range — – — · 0 analysts
Next period, 0 analysts expect Bioceres Crop Solutions Corp to earn — a share (range — – —), versus — a year earlier.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 0 analysts
Revenue is expected to reach $0 (range $0 – $0)., rising to $0 next year.
Top analysts covering Bioceres Crop Solutions Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BIOX.
#1
Scott Fortune
Roth MKM · Rank #307
Buy
$13.00+2981.3% to target
Overall win rate
35%
+ Follow
#2
Austin Moeller
Canaccord Genuity · Rank #310
Hold
$2.00+374.0% to target
Overall win rate
32%
+ Follow
#3
Kristen Owen
Oppenheimer · Rank #351
Buy
$6.00+1322.1% to target
Overall win rate
22%
+ Follow
#4
Ben Klieve
Lake Street · Rank #399
Buy
$5.00+1085.1% to target
Overall win rate
27%
+ Follow
#5
BK
Ben Klieve
Benchmark Co.
Buy
$5.00+1085.1% to target
Coverage
—
+ Follow
BIOX stock forecast FAQ
What is BIOX's average 12-month price target?+
The 2 analysts with a live target average $3.50 for Bioceres Crop Solutions Corp over the next 12 months, ranging from a $5.00 high to a $2.00 low.
Is BIOX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 2 analyst ratings, 1 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for BIOX?+
The Street-high target is $5.00 (Lake Street), and the Street-low is $2.00 (Canaccord Genuity). The average of all 2 active targets is $3.50.
How many Wall Street analysts cover BIOX?+
2 analysts have an active rating on Bioceres Crop Solutions Corp, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering BIOX?+
Among analysts who currently cover BIOX, Scott Fortune of Roth MKM has the strongest overall Quantellect track record (Rank #307). Their current call is Buy with a $13.00 target.
What is Bioceres Crop Solutions Corp's projected EPS for next quarter?+
The consensus estimate is — per share (range — – —) across 0 analysts, rising to — the following year.
How much revenue is Bioceres Crop Solutions Corp expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0), growing to $0 next year.
Have analysts been upgrading or downgrading BIOX lately?+
As of Aug, 1 of 2 firms rate BIOX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BIOX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
